Sjoerd H. den Uil

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients

M. A. van de Wiel, B. Ylstra, G. Meijer, 2016, Oncotarget.

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study

G. Meijer, H. Stockmann, E. Belt, 2019, BMC Gastroenterology.

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence

G. Meijer, H. Stockmann, J. Samsom, 2022, Scientific Reports.

Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.

G. Meijer, R. Slebos, H. Stockmann, 2020, European journal of cancer.

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

G. Meijer, L. Vermeulen, J. Medema, 2016, British Journal of Cancer.

Aortic arch thrombus caused by nitrous oxide abuse

E. Vermeulen, R. Metz, A. Rijbroek, 2018, Journal of vascular surgery cases and innovative techniques.

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer

G. Meijer, H. Stockmann, R. Fijneman, 2018, Oncotarget.

Small Bowel Perforation Caused by Advanced Melanoma

H. Stockmann, E. Vermeulen, I. Thomassen, 2014, Tumori.

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

G. Meijer, B. Carvalho, C. Pritchard, 2015, Oncotarget.